Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care. PPN is a division of RxPR, LLC.
Episodes
Episodes



Friday Aug 12, 2022
Friday Aug 12, 2022
Join host, Jenna Carmichael, PharmD for a discussion on the role of Nitric Oxide in immune health with guest, Beth Shirley, RPh, CCN.
Beth Shirley, RPh CCN is a Registered Pharmacist and Certified Clinical Nutritionist who has developed unique expertise as both a pharmacist and certified clinical nutritionist during a distinguished 40+ year career which she has been a pioneer at the cutting edge of the evolution of what has now come to be known as “Integrative Pharmacy” ...the junction between traditional pharmacy and the clinical use of nutritional supplementation.
Since 2009, Beth has worked in close collaboration with some of the world’s leading thought leaders in the field of nitric oxide research. Through this, she has developed an in-depth knowledge on the topic and its potential beneficial applications in multiple aspects of patient care. In addition, she has worked closely with the scientific community and cutting-edge companies working on innovative nutritional ingredients and approaches to their use for a variety of life’s challenges.
Beth is currently the Executive Director of Berkeley Life Scientific Advisory Board.
Article link: https://bit.ly/3bX2Y7h
YouTube Reference: https://www.youtube.com/watch?v=qnyaRVOdhYM
To order Berkeley Life go to: https://www.berkeleylife.com/berkeley-life-direct/ and use code JCARMBL
Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com for more information on her services.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Thursday Aug 11, 2022
Thursday Aug 11, 2022
Significant challenges to widescale clinical implementation of PGx include a lack of physician experience using PGx test data or confidence in interpreting PGx test data and integrating the data into the medication therapy management process. For PGx to be most impactful, prescribers must consider PGx data within the context of other non-genetic patient-specific factors. Pharmacists may help prescribers with PGx test data by creating a summary of medication therapy management recommendations for the patient that streamlines PGx report flags and identifies other pharmacotherapy interventions the pharmacist recognizes while applying non-genetic patient-specific data to the PGx test data.
In this episode of the PGx for Pharmacists podcast, Dr. Becky Winslow discusses the research study, "Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation," with two of the research investigators, Dr. Anna Langerveld and Dr. David Bright. Dr. Langerveld and Dr. Bright share how this research adds to the growing evidence that clinical pharmacists can help improve the utility of PGx and prescribing. They also share how their study described a process for reducing PGx laboratory report information to a single page of patient-specific clinical recommendations. Lastly, they share that while clinical decision support tools are becoming more routine for pharmacogenomic management, the pharmacists in this study reduced the number of report-based alerts independent of sophisticated clinical decision support informatics.
Anna Langerveld, Ph.D., is the Founder and President of Genemarkers, a contract research organization and CLIA/CAP certified testing laboratory specializing in genomics. Anna received her B.A. in Psychology from SUNY Binghamton and her Ph.D. from the Interdisciplinary Program in Neurosciences at Tulane University. After receiving her Ph.D., Anna served as a Research Assistant Professor at Western Michigan University. She founded Genemarkers in 2008. Under her leadership, Michigan Celebrates Small Business recognized the Company as one of the Top 50 Michigan Companies to watch.
Anna is an author of peer-reviewed publications, an NIH grant recipient, and an invited speaker at a wide range of national meetings. Anna currently serves as an adjunct professor and an advisory board member for the Manchester University pharmacogenomics program and holds a community faculty position at the Western Michigan University Homer Stryker M.D. School of Medicine.
Anna has been instrumental in developing strategic community partnerships to implement the use of genomics in clinical care, with a particular focus on mental health and underserved populations.
Dr. David Bright is a Professor of Pharmacy at Ferris State University, where he has taught therapeutics and medication therapy management. He received his PharmD degree from the University of Toledo, completed a community pharmacy residency with Kroger Pharmacy and the University of Toledo, and served on the faculty at the Ohio Northern University as a community pharmacy residency program director. His research has primarily involved the pragmatic implementation and improvement of non-dispensing pharmacy services, particularly in the outpatient setting. Most recently, that has involved the integration of pharmacogenomics into clinical practice through community pharmacy and ambulatory care practice models.
Research discussed in the podcast episode:
Bright D, Saadeh C, DeVuyst-Miller S, Sohn M, Choker A, Langerveld A. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation. Pharmgenomics Pers Med. 2020 Dec 10;13:719-724. doi: 10.2147/PGPM.S276687. PMID: 33328756; PMCID: PMC7735940. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735940/
Learn more about your ad choices. Visit megaphone.fm/adchoices



Wednesday Aug 10, 2022
Gender Affirmed: Inclusion in the Pharmacy | Transforming a Nation
Wednesday Aug 10, 2022
Wednesday Aug 10, 2022
The first in a four-part series detailing medication access for gender-diverse individuals in light of increasingly restrictive legislative action.
As front-line healthcare workers, it’s incumbent upon pharmacists to be paragons of not only equality but equity in healthcare. Gender expansive and nonbinary patients face a massive disparity of outcomes, many of which are improved with gender-affirming therapy. With the expansion of pharmacists’ roles in healthcare, many cases of gender-affirming therapy are often overseen or monitored by pharmacists. The world is changing, and the landscape of healthcare with it.
Our audience of pharmacists, pharmacy students, and other healthcare providers need to hear the stories of gender-diverse patients, pharmacists, and advocates who will stop at nothing to bridge the gap to care.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Tuesday Aug 09, 2022
Tuesday Aug 09, 2022
Mindy Ferris, RPh, EVP, Operations & Customer Success, and Michael Gerdes, RPh, CCP, Director of Clinical Systems, both at PharmScript, LLC, join our hosts for a candid conversation about long-term care pharmacy growth, transition of care, technology, and how the commitment to caring for people remains key.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Monday Aug 08, 2022
HIV Prevention and Treatment | Sex PharmD
Monday Aug 08, 2022
Monday Aug 08, 2022
https://www.michrxconsulting.com/
https://www.linkedin.com/in/michellejsherman/
https://pharmacypodcast.com/podcast/conscious-pharmacist-podcast/
Learn more about your ad choices. Visit megaphone.fm/adchoices



Friday Aug 05, 2022
Friday Aug 05, 2022
Integrative Pharmacy Solutions to Inflammation and Oxidation w/Beth Shirley
Hi dear listeners! I’m excited to announce the guest of the next two episodes will be Beth Shirley, and she will talk about the wonders happening in the world of nitric oxide supplementation. Today we dive into her personal and professional journey and next week we feature a journal club article with my cohost Jenna Carmichael.
Beth Shirley, RPh CCN is a Registered Pharmacist and Certified Clinical Nutritionist who has developed unique expertise as both a pharmacist and certified clinical nutritionist during a distinguished 40+ year career. Her specialties include stress-induced hormonal imbalance, intestinal dysfunction, autoimmune and chronic inflammatory issues, detoxification, nutrigenomics and super-normal oxidative stress.
She has been a pioneer at the cutting edge of the evolution of what has now come to be known as “Integrative Pharmacy” ...the junction between traditional pharmacy and the clinical use of nutritional supplementation.
Since 2009, Beth has worked in close collaboration with some of the world’s leading thought leaders in the field of nitric oxide research. Through this, she has developed an in- depth knowledge on the topic and its potential beneficial applications in multiple aspects of patient care.
In addition, she has worked closely with the scientific community and cutting-edge companies working on innovative nutritional ingredients and approaches to their use for a variety of life’s challenges.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Thursday Aug 04, 2022
Cardinal Health 2022 RBC Summary Show
Thursday Aug 04, 2022
Thursday Aug 04, 2022
This is the Cardinal Health 2022 Retail Business Conference summary show.
The Pharmacy Podcast Network was BACK at this years Cardinal RBC in Las Vegas!
Listen to our interviews with:
Brad Jones, CEO of RMS, Retail Management Solutions
Chris Halko, the owner and pharmacist of both Fort Benton and Big Sandy Pharmacies in Montana.
Imad Karaze, Pharmacist and Owner, Beaumont Pharmacy
Debbie Weitzman, President of Pharmaceutical Distribution at Cardinal Health."
Greco De Valencia, Vice President of Pharmacy at Live Oak Bank. Live Oak
Attendees came together at the Mandalay Bay Conference center in Las Vegas from July 13 to 16, marking the 30th anniversary of the Cardinal Health’s RBC event.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Wednesday Aug 03, 2022
A New Platform for Continuing Education through Podcasts: Introducing ConveyMED
Wednesday Aug 03, 2022
Wednesday Aug 03, 2022
ConveyMED, a division of Convey Pro, Inc. today announced a new partnership with the Pharmacy Podcast Network. With ConveyMED, PPN content creators can now deliver a superior educational experience to pharmacists on a proprietary podcast platform designed to optimize the medical education experience.
“We are thrilled to partner with the Pharmacy Podcast Network to provide mobile medical education to the integrated treatment team,” says Mike Donoghue, CEO at ConveyMED. “The PPN is a pioneer in podcast medical education. Our vision is to elevate podcasting as a medium for medical education for all healthcare providers and we welcome all pharmacists to the industry-leading ConveyMED App.”
“The Pharmacy Podcast Network has been searching for a platform like ConveyMED for years,” stated Todd S. Eury, founder and CEO of PPN. “Our vision is to provide peer-reviewed, accredited content to our listeners to help them achieve their educational goals and improve patient care. The ConveyMED App exceeds our expectations, and their Founders are committed to a bold new educational experience for healthcare providers.”
In this partnership, Content Creators will have access to a podcast platform that will allow them to broaden their educational offerings and monetize their content. Pharmacists will benefit by accessing peer-reviewed educational content in a popular mobile format and earn continuing education credit on-the-go. ConveyMED invites all 130,000+ monthly PPN listeners to its platform.
The first premium audio content to be released on the ConveyMED platform will be the NAPLEX Podcast developed by Dr. Chloe Givens PharmD. The NAPLEX Podcast is a supplemental learning collection of 70+ podcast episodes to help pharmacy students prepare for the North American Pharmacist Licensure Examination.
INTERESTED IN WORKING WITH OTHER PODCAST CONTENT CREATORS?
Contact us: https://conveymed.io/pharmacy-podcast-network/
About ConveyMED: ConveyMED is Medical Education for the Mobile Generation. We exist to bring educators and professional learners together on a podcast platform built for continuing education and provide them with the most robust podcast learning experience possible.
For more information, visit the ConveyMED website, Twitter, or LinkedIn
About the Pharmacy Podcast Network: The first network of podcasters dedicated to the pharmacy industry, PPN boasts 40+ content developers, 125,000 listeners, and is ranked in the top 2% of all podcasts globally. The PPN partners with multiple leading organizations such as the American Pharmacist Association, the California Pharmacist Association, and Pennsylvania Pharmacist Association, and the National Association of Specialty Pharmacies. PPN was awarded the 2022 Health & IT Marketing Community (HITMC) Podcast of the Year.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Tuesday Aug 02, 2022
Transforming Patient Engagement with LifeLink Systems
Tuesday Aug 02, 2022
Tuesday Aug 02, 2022
We talk with Greg Johnsen, CEO at Lifelink Systems, Inc.
#TogetheRx we are transforming patient engagement across the healthcare industry by giving hospital systems and life sciences companies advanced conversational technology to interact with patients where they spend their time — messaging on mobile devices. Our technology turns the smartphone into the next-generation healthcare worker, capable of handling complex workflows at unlimited scale.
Information technology has come a long way, but successful user engagement has proven to be a surprisingly daunting last-mile challenge. Healthcare is complicated and the digital tools offered to patients reflect that, which results in low adoption and satisfaction. Delivering digital patient experiences remains a strategic priority, but the healthcare industry needs to reimagine patient-facing technology. The challenge remains: How do we make the complex exceedingly simple, exceedingly intuitive?
It turns out that the simplest, most intuitive human interface is a conversation. It’s natural, requires no training, is infinitely flexible, self-directed, and responsive. With smartphone adoption rates approaching 90%, the opportunity to engage in conversation-based information exchanges is in the palms of everyone’s hands. Today, any human with a mobile phone can converse with complex IT systems with ease, and immediately, by relying on smart, context-aware digital assistants.
The technology for enabling conversational AI will transform consumer engagement strategies across every industry sector, but it will have an especially profound impact on process-centric customer care industries. Like Healthcare.
Conversational AI not only closes a service gap, it improves the quality of the service itself while also providing the engagement horsepower to scale up service operations profitably. Digital assistants carry the encoded protocols, orders, and best practices to the patient in the form of smart, engaging conversations.
Importantly, conversational AI technology doesn’t replace human expertise and services, it augments care teams by taking on all of the redundant, high-volume processes. Companies that are taking advantage of this powerful new technology are transforming the patient experience, and dramatically improving customer service across the board.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Tuesday Aug 02, 2022
To MME or Not to MME, Is There a Question? | PAIN POD
Tuesday Aug 02, 2022
Tuesday Aug 02, 2022
Let’s face it, when it comes to pain management, one of the most painful efforts of the last few years has involved, in one way, shape, form, or fashion: Morphine Milligram Equivalents (MMEs). As we discussed with the PharmD author of the 2022 CDC Opioid Guideline Update , there are no MME factor changes on the horizon, so just when will we have our minds wrapped around the concept?!?
Join the Mark “Pain Guy” Garofoli on the Pain Pod for a dynamic discussion on wrestling (yes, you read that right!), pain management, our healthcare system, and the “street” version of MMEs. Wait, there’s a street version of MMEs? Yes, yes there is, so tune in now to the Pain Pod as you’ll only utilize the edge of your seat even though ya paid for the whole seat!
Come one, come all, to the Pain Pod!!!
Episode Notes
Pre-2016 MME Charts Review
2016 CDC Chronic Pain Opioid Guideline MME Chart
· CDC Chronic Pain Opioid Guidelines: MMWR March 2016. Updated 2017.
o Tramadol: 0.1
o Codeine: 0.15
o Tapentadol: 0.4
o Morphine: 1
o Hydrocodone: 1
o Oxycodone: 1.5
o Oxymorphone: 3
o Hydromorphone: 4
o Methadone (Up to: 20mg, 40mg, 60mg, >60mg): 4, 8, 10, 12
o Transdermal Fentanyl: 7.2 (Divided by the # of Days Applied)
o Transdermal Buprenorphine: 12.6 (Divided by the # of Days Applied)
o Buprenorphine (SL or Buccal): 0.03 (for mcg calculations) or 30 (for mg calculations)
· Nielson S. et. al. A synthesis of oral morphine equivalents (OME) for opioid utilization studies. Pharmacoepidemiology and drug safety 2016; 25: 733–737
2015 Cat and Dog MME Article
· https://burrardvet.com/2015/04/08/pain-control-in-dogs-cats
2016 CDC Chronic Pain Opioid Guideline MME Chart
· CDC Chronic Pain Opioid Guidelines: MMWR March 2016. Updated 2017.
2022 CDC Opioid Guideline Revision Resources
· https://www.federalregister.gov/documents/2022/02/10/2022-02802/proposed-2022-cdc-clinical-practice-guideline-for-prescribing-opioids
2010 to 2014 MME Relative Risk of Overdose/Death
· https://i1.wp.com/face-facts.org/wp-content/uploads/2017/04/Opioid-dose-vs-overdose-risk.jpg
Missouri Marijuana Equivalents (MMEs)
· https://north.life/demystifying-missouri-medical-marijuana-equivalency-units-mmes/
Audio Add-in’s
Let’s Get Ready to Rumble (Michael Buffer)
· https://www.youtube.com/watch?v=jgopHWACUXs
Cash sound
· https://www.youtube.com/watch?v=ZeET7Z1ZGlw
Ron Burgundy “That Escalated Quickly”
· https://www.youtube.com/watch?v=FONN-0uoTHI
Learn more about your ad choices. Visit megaphone.fm/adchoices



Monday Aug 01, 2022
The Impact of a Nitric Oxide Supplement | Pharmacy Profit Summit 2022
Monday Aug 01, 2022
Monday Aug 01, 2022
Your ability to produce Nitric Oxide (N-O) declines rapidly as you age. Berkeley Life Professional’s proprietary dietary nitrate blend provides the plant-based bio-equivalents of a leafy green diet in each two capsule dose helping you maintain Nitric Oxide levels as you age. This interview with Berkeley Life CEO John Halbert is a terrific testimonial to the importance of the supplement and to the revenue opportunity for community pharmacies. RxSafe, RMS, and Berkeley Life will be sponsoring the 2022 Pharmacy Profit Summit in Dallas Texas hosted by DiversifyRx.
Learn more: https://www.berkeleylife.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices



Monday Aug 01, 2022
How Interest Rate Hikes Affect Pharmacy Owners | Live Oak Bank
Monday Aug 01, 2022
Monday Aug 01, 2022
In this episode, Greco DeValencia of Live Oak Bank and Owen BonDurant and Rich Danhof of Independent Rx discuss the recent rate hikes, how it affects current pharmacy owners and owners to be and what to be concerned about beyond just the headlines of rising rates.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Friday Jul 29, 2022
Friday Jul 29, 2022
Accreditation and support statement:
· PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
· This activity is supported by educational grant from GlaxoSmithKline.
Objectives
• Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer.
• Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Friday Jul 29, 2022
Friday Jul 29, 2022
Educational Objectives
· Discuss currently available options for pre-exposure prophylaxis (PrEP) in the prevention of HIV.
· Describe the role of pharmacists in improving PrEP uptake in the United States.
Faculty:
Drew W. Cates, PharmD, AAHIVP,
Educational Manager
SynerGrx
Chamblee, Georgia
Faculty, has the following financial relationships with commercial interests to disclose:
Speaker's Bureau: Gilead
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.07 CEU) under the ACPE universal activity number 0290-0000-22-338-H02-P. The activity is available for CE credit through July 29, 2023.
This activity is supported by an educational grant from ViiV.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Friday Jul 29, 2022
Friday Jul 29, 2022
Educational Objectives
• Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC)
• Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations
Josiah D. Land, PharmD, BCOP
Clinical Pharmacy Specialist – Thoracic Medical Oncology
Department of Pharmacy
Memorial Sloan Kettering Cancer Center
New York, New York
Josiah D. Land, PharmD, BCOP, has the following financial relationship with a commercial interest to disclose:
Consultant (advisory board): Bristol Myers Squibb
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number0290-0000-22-388-H01-P. The activity is available for CE credit through July 29, 2023.
This activity is supported by educational funding provided by Amgen.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Friday Jul 29, 2022
”Sex Matters” with Dr Alyson McGregor | Sex PharmD
Friday Jul 29, 2022
Friday Jul 29, 2022
This episode interviews Dr Alyson McGregor, MD Professor of Emergency Medicine and Associate Dean of Clinical Faculty Affairs and Development at University of South Carolina School of Medicine Greenville.
Dr McGregor is a sex and gender expert, educator and advocate. Dr McGregor discusses her book, Sex Matters: How Male-Centric Medicine Endangers Women's Health and What We Can Do About It.
https://www.alysonmcgregormd.com/
@amcgregormd
Learn more about your ad choices. Visit megaphone.fm/adchoices



Thursday Jul 28, 2022
Thursday Jul 28, 2022
Educational Objectives
· Review the efficacy and safety of emerging frontline immune checkpoint inhibitor (ICI) used as monotherapy and in combination regimens
· Indicate the impact of ICIs and programmed death-ligand 1 testing on cost-effectiveness and patient reported outcomes related with frontline use of ICIs in advanced NSCLC
Faculty:
Paul Forsberg, PharmD, MHA, BCOP
Director of Pharmacy
Minnesota Oncology
St. Paul, Minnesota
Latha Radhakrishnan, PharmD, BCOP
Clinical Oncology Pharmacist
The University of Illinois Hospital and Health Sciences System
Clinical Assistant Professor
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois
Paul Forsberg, PharmD, MHA, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Epizyme
Speakers Bureau: AstraZeneca
Latha Radhakrishnan, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Taiho, Novartis, Exelixis
Speakers Bureau: BMS, AstraZeneca, Taiho, Exelixis
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.
Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-22-363-H01-P. The activity is available for CE credit through July 29, 2023.
This activity is supported by independent medical education grants from Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Inc., and Sanofi Genzyme.
https://www.pharmacytimes.org/courses/continuing-the-conversation-optimizing-frontline-immunotherapy-outcomes-in-nsclc-and-managed-care-considerations
Learn more about your ad choices. Visit megaphone.fm/adchoices



Thursday Jul 28, 2022
4 Can’t Miss Trends about Digital Engagement with Ritesh Patel | DarshanTalks
Thursday Jul 28, 2022
Thursday Jul 28, 2022
4 Can't Miss Trends about Digital Engagement! Coming up on Friday's livestream of the DarshanTalks Podcast with host Darshan Kulkarni and guest Ritesh Patel, originally streamed on July 15th, 2022.
Learn more about your ad choices. Visit megaphone.fm/adchoices



Wednesday Jul 27, 2022
Implementing G6 into Pharmacy Practice | Real Time Real Talk
Wednesday Jul 27, 2022
Wednesday Jul 27, 2022
Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to Dexcom G6 User Guide. For product-related questions, please refer to instructions for use. For complete safety information, go to dexcom.com/safety-information Smart devices are sold separately. For a list of compatible smart device visit Dexcom.com/compatibility
Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.
The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older.
Dexcom G6 System User Guide
Safety Information https://www.dexcom.com/safety-information
Dexcom Follow app: The Dexcom G6 App allows you to share your glucose data with up to 10 people. By downloading the Dexcom Follow App, followers can view your glucose data directly from their smart device† whether they live down the street or across the country*.
Connectivity – basics (https://provider.dexcom.com/dexcom-cgm/collaborators)
About Dexcom https://www.dexcom.com/about-Dexcom
Beacon Health System Resources
Dexcom Patient Training and Resources
Dexcom Prescribing Information
Brief Safety Statement
Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
The web-based Dexcom CLARITY software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional.
Dexcom, Dexcom Follow, Dexcom CLARITY, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries.
References:
1. William H. Polonsky, Emily C. Soriano, and Addie L. Fortmann. Diabetes Technology & Therapeutics. Ahead of print http://doi.org/10.1089/dia.2021.0526
2. Shah VN, et al. Diabetes Technology & Therapeutics. 2018;20(S1):A-27 DOI: 10.1089/dia.2018.0143
3. Kaushik S, et al. Diabetes. 2020 Jun;69(Supplement 1) https://doi.org/10.2337/db20-79-LB
Learn more about your ad choices. Visit megaphone.fm/adchoices



Tuesday Jul 26, 2022
The Good, The Bad, & The Ignorant: The Twisted World of PCMA Politics | PUTTcast
Tuesday Jul 26, 2022
Tuesday Jul 26, 2022
Solid PR practices call for changing the conversation to one's advantage, but PCMA's recent OpEds based on a paid-for white paper are more than suspect.
Listen in as lobbyist & managing partner of Public Policy Partners Meghaen Della'Artino, and General Counsel for American Pharmacies Miguel Rodriguez, speak with PUTTcast host Monique Whitney about strategy, the current political arena, and how the power of grassroots and a constituent's voice can overcome the most well-funded PBM politics.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Podcast Network
With 40+ different podcast programs and over 50+ different co-hosts helping to develop audio content about different subjects in pharmacy, the PPN delivers a unique publication to all healthcare professionals with a specific focus on pharmacy.